Zhang et al. [21] predicted that the PPAR signalling pathway is the key target pathway of Shen-Hong-Tong-Luo (SHTL) against atherosclerosis (AS) and verified that SHTL activates the PPAR pathway and reduces the inflammatory response and lipid accumulation in macrophages, thus reducing the symptoms of AS. This evidence concerns the gene PPARA and atherosclerosis.